Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Alopecia areata in these mice is inherited, more common in young females, and can be treated with triamcinolone acetonide.

Alopecia areata is caused by the immune system attacking hair follicles.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Apremilast may help treat hair loss in alopecia areata.

JAK inhibitors might help treat alopecia areata.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Alopecia Areata might be linked to Crohn's disease.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Ginsenoside Rg3 may help hair growth by increasing a growth-related protein in hair cells.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

ILC1-like cells can independently cause alopecia areata.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Plucked hair follicles can help diagnose scalp lupus.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Symmetrical Acrokeratoderma (SAK) may be a unique skin condition in China, lacking specific treatment and needing long-term monitoring.